SCHEMBL7186746

SCHEMBL7186746

COc1c(C=CC(=O)c2ccc(OC(=O)C(C)(C)C)cc2)cc(C(C)C)c(OC(=O)C(C)(C)C)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 9/20 0.46
ABCG2 Q9UNQ0 3/20 0.44
GABRA3 P34903 1/20 0.43
GABRA2 P47869 1/20 0.43
GABRB2 P47870 1/20 0.43
TNFRSF1A P19438 1/20 0.43
DPP4 P27487 2/20 0.42
IDH1 O75874 1/20 0.42
ABCB1 P08183 1/20 0.42
UGT1A1 P22309 1/20 0.42
ABCC1 P33527 1/20 0.42
PRMT6 Q96LA8 1/20 0.42
KRAS P01116 1/20 0.42
ELANE P08246 1/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
MAPK1 P28482 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7190078 0.94 PTPN1 (0.43) PTPN1ABCG2GABRA3GABRA2GABRB2
SCHEMBL7191627 0.93 CYP1A1 (0.47) PTPN1ABCG2DPP4LMNAMAPT
SCHEMBL7191564 0.92 PTPN1 (0.44) PTPN1ABCG2GABRA3GABRA2GABRB2
SCHEMBL7191566 0.92 PTPN1 (0.44) PTPN1ABCG2GABRA3GABRA2GABRB2
SCHEMBL7181226 0.91 DPP4 (0.46) PTPN1ABCG2DPP4LMNAMAPT
SCHEMBL7188986 0.87 ABCG2 (0.44) PTPN1ABCG2TNFRSF1AKRASELANE
SCHEMBL7188991 0.87 ABCG2 (0.44) PTPN1ABCG2TNFRSF1AKRASELANE
SCHEMBL9276302 0.87 PTPN1 (0.42) PTPN1DPP4LMNAMAPTKDM4E
SCHEMBL7184153 0.86 PTPN1 (0.48) PTPN1ABCG2GABRA3GABRA2GABRB2
SCHEMBL7184167 0.86 TNFRSF1A (0.53) PTPN1ABCG2GABRA3GABRA2GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed